Literature DB >> 2448137

Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand.

Y Yarden1, W J Kuang, T Yang-Feng, L Coussens, S Munemitsu, T J Dull, E Chen, J Schlessinger, U Francke, A Ullrich.   

Abstract

Structural features of v-kit, the oncogene of HZ4 feline sarcoma virus, suggested that this gene arose by transduction and truncation of cellular sequences. Complementary DNA cloning of the human proto-oncogene coding for a receptor tyrosine kinase confirmed this possibility: c-kit encodes a transmembrane glycoprotein that is structurally related to the receptor for macrophage growth factor (CSF-1) and the receptor for platelet-derived growth factor. The c-kit gene is widely expressed as a single, 5-kb transcript, and it is localized to human chromosome 4 and to mouse chromosome 5. A c-kit peptide antibody permitted the identification of a 145,000 dalton c-kit gene product that is inserted in the cellular plasma membrane and is capable of self-phosphorylation on tyrosine residues in both human glioblastoma cells and transfected mouse fibroblasts. Our results suggest that p145c-kit functions as a cell surface receptor for an as yet unidentified ligand. Furthermore, carboxy- and amino-terminal truncations that occurred during the viral transduction process are likely to have generated the transformation potential of v-kit.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2448137      PMCID: PMC553789          DOI: 10.1002/j.1460-2075.1987.tb02655.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  47 in total

1.  Low level of cellular protein phosphorylation by nontransforming overproduced p60c-src.

Authors:  H Iba; F R Cross; E A Garber; H Hanafusa
Journal:  Mol Cell Biol       Date:  1985-05       Impact factor: 4.272

2.  A method for isolation of intact, translationally active ribonucleic acid.

Authors:  G Cathala; J F Savouret; B Mendez; B L West; M Karin; J A Martial; J D Baxter
Journal:  DNA       Date:  1983

3.  Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor.

Authors:  T Yamamoto; S Ikawa; T Akiyama; K Semba; N Nomura; N Miyajima; T Saito; K Toyoshima
Journal:  Nature       Date:  1986 Jan 16-22       Impact factor: 49.962

4.  Isolation and expression of an altered mouse dihydrofolate reductase cDNA.

Authors:  C C Simonsen; A D Levinson
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

5.  Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells.

Authors:  A Ullrich; L Coussens; J S Hayflick; T J Dull; A Gray; A W Tam; J Lee; Y Yarden; T A Libermann; J Schlessinger
Journal:  Nature       Date:  1984 May 31-Jun 6       Impact factor: 49.962

6.  The transforming proteins of Rous sarcoma virus, Harvey sarcoma virus and Abelson virus contain tightly bound lipid.

Authors:  B M Sefton; I S Trowbridge; J A Cooper; E M Scolnick
Journal:  Cell       Date:  1982-12       Impact factor: 41.582

7.  In vitro phosphorylation of the 36K protein in extract from Rous sarcoma virus-transformed chicken fibroblasts.

Authors:  N Kobayashi; A Tanaka; A Kaji
Journal:  J Biol Chem       Date:  1981-03-25       Impact factor: 5.157

8.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

9.  Expression in rat fibroblasts of a human transforming growth factor-alpha cDNA results in transformation.

Authors:  A Rosenthal; P B Lindquist; T S Bringman; D V Goeddel; R Derynck
Journal:  Cell       Date:  1986-07-18       Impact factor: 41.582

10.  Amino terminal myristylation of the protein kinase p60src, a retroviral transforming protein.

Authors:  A M Schultz; L E Henderson; S Oroszlan; E A Garber; H Hanafusa
Journal:  Science       Date:  1985-01-25       Impact factor: 47.728

View more
  346 in total

1.  Expression of the intermediate filament nestin in gastrointestinal stromal tumors and interstitial cells of Cajal.

Authors:  T Tsujimura; C Makiishi-Shimobayashi; J Lundkvist; U Lendahl; K Nakasho; A Sugihara; T Iwasaki; M Mano; N Yamada; K Yamashita; A Toyosaka; N Terada
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

Review 2.  Mast cells. Receptors, secretagogues, and signaling.

Authors:  Bhavya B Sharma; John R Apgar; Fu-Tong Liu
Journal:  Clin Rev Allergy Immunol       Date:  2002-04       Impact factor: 8.667

3.  One-step detection of c-kit point mutations using peptide nucleic acid-mediated polymerase chain reaction clamping and hybridization probes.

Authors:  Karl Sotlar; Luis Escribano; Olfert Landt; Stefanie Möhrle; Sonia Herrero; Antonio Torrelo; Ulrich Lass; Hans-Peter Horny; Burkhard Bültmann
Journal:  Am J Pathol       Date:  2003-03       Impact factor: 4.307

Review 4.  Targeting KIT in melanoma: a paradigm of molecular medicine and targeted therapeutics.

Authors:  Scott E Woodman; Michael A Davies
Journal:  Biochem Pharmacol       Date:  2010-05-08       Impact factor: 5.858

5.  Mutations in exons 9 and 13 of KIT gene are rare events in gastrointestinal stromal tumors. A study of 200 cases.

Authors:  J Lasota; A Wozniak; M Sarlomo-Rikala; J Rys; R Kordek; A Nassar; L H Sobin; M Miettinen
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

Review 6.  Molecular basis and management of gastrointestinal stromal tumors.

Authors:  Ulas D Bayraktar; Soley Bayraktar; Caio M Rocha-Lima
Journal:  World J Gastroenterol       Date:  2010-06-14       Impact factor: 5.742

7.  Ciprofloxacin increases survival after ionizing irradiation combined injury: γ-H2AX formation, cytokine/chemokine, and red blood cells.

Authors:  Juliann G Kiang; Risaku Fukumoto
Journal:  Health Phys       Date:  2014-06       Impact factor: 1.316

8.  Biphasic expression of two paracrine melanogenic cytokines, stem cell factor and endothelin-1, in ultraviolet B-induced human melanogenesis.

Authors:  Akira Hachiya; Akemi Kobayashi; Yasuko Yoshida; Takashi Kitahara; Yoshinori Takema; Genji Imokawa
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

9.  Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis.

Authors:  B J Longley; D D Metcalfe; M Tharp; X Wang; L Tyrrell; S Z Lu; D Heitjan; Y Ma
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

10.  Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder.

Authors:  H Nagata; A S Worobec; C K Oh; B A Chowdhury; S Tannenbaum; Y Suzuki; D D Metcalfe
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.